Curelo

Curelo

Supplier of a health app for booking lab tests

Founded

2022

Headquarters

Gurugram (India)

Status

Seed

Company Details

Website

Socials

Email

Phone

+91 8069770000

Curelo operates in the healthtech sector as a digital aggregator platform for diagnostic labs, serving urban and semi-urban markets provides a one-stop solution for booking lab tests, home sample collection, and digital report delivery, connecting patients with over 1,500 certified labs and offering 5,000+ diagnostic tests. Curelo’s tech-driven, asset-light model enables patients to book tests from any lab of their choice, with free home sample collection and rapid turnaround. The company’s CURELO FLASH service—India’s first 10-minute doorstep blood sample collection—sets a new benchmark for convenience and speed in diagnostics.

 Core Products and Services

  • Lab Test Aggregation Platform: Digital marketplace allowing users to book 3,000+ tests from 1,500+ labs, with transparent pricing and lab selection.

  • Home Sample Collection: Free, certified phlebotomist-led sample collection at the patient’s preferred time and location, available 24/7 in select cities.

  • CURELO FLASH: 10-minute doorstep blood sample collection service, currently live in Gurugram and expanding to other cities—an industry-first for speed and convenience.

  • Digital Health App: Enables test booking, prescription uploads, report management, and access to health and wellness content.

  • No-Cost EMI for Lab Tests: First in India to offer zero-interest EMI options on all lab tests, reducing financial barriers for patients.

  • Wellness Packages & Preventive Health: Curated health checkup packages and preventive screening panels, with digital delivery of results

 Business Model & Revenue Streams

  • Commission-Based Revenue: Core revenue from commissions on each test booked through the platform, paid by partner labs.

  • Service Fees: Additional income from value-added services such as CURELO FLASH, wellness packages, and digital health subscriptions.

  • B2B Partnerships: Revenue from onboarding and standardizing unorganized labs, as well as providing technology integration and operational support

 Top Clients & Partnerships

  • Diagnostic Lab Network: Over 1,500 partner labs nationwide, including both standalone and hospital-based facilities, ensuring broad test availability and geographic reach.

  • Strategic Investors & Ambassadors: IIMA Ventures (IIM Ahmedabad’s fund), Shreyas Iyer (cricketer and brand ambassador), Tarun Katial (Zee5 co-founder), and US family offices—providing capital, strategic guidance and brand visibility. Dr. Arpit Jayswal (founder and CEO) brings deep healthcare and diagnostics expertise.

  • Technology & Logistics Partners: Collaborations for logistics, IoT, and digital health integration to ensure sample integrity and rapid turnaround

 Future Outlook & Strategic Priorities

  • Geographic Expansion: Aggressively scaling CURELO FLASH and home collection services to new cities, targeting a 300% increase in patient base by 2025 (reflecting recent market trends).

  • Product Innovation: Expanding into radiology and blood bank aggregation, and developing new at-home healthcare services tailored to diverse patient needs.

  • Technology Investment: Continued enhancement of the digital platform, AI-driven patient engagement, and operational automation to improve user experience and efficiency.

  • Regulatory Uncertainty: Evolving healthcare and diagnostics regulations could impact compliance costs and operational flexibility, especially as Curelo scales national.

Key People

Parth Jaiswal

Amit Arora

Key Metrics

Total Equity Funding

$2.3 Million

No. of Funding Rounds

2

Latest Funding Round

$2.2 Million, Seed

as of March 15, 2024

Post Money Valuation

$10.4 Million

as of April 5, 2025

Funding Multiple

4.7

as of April 5, 2025

Investors

IIMA Ventures

Employee Count

108

Similar Companies

Orange health

Exit Details

N/A

All Funding Rounds

DateRound NameAmountValuationRevenueRevenue Multiple
Investors
March 15, 2024Seed$2.2 Million-$714 K- IIMA Ventures
January 5, 2023Seed$100 K$8 Million-- IIMA Ventures

Recent News